PT3331508T - Solução de injeção hiperbárica de cloridrato de levobupivacaína compreendendo cloridrato de levobupivacaína - Google Patents
Solução de injeção hiperbárica de cloridrato de levobupivacaína compreendendo cloridrato de levobupivacaínaInfo
- Publication number
- PT3331508T PT3331508T PT168240034T PT16824003T PT3331508T PT 3331508 T PT3331508 T PT 3331508T PT 168240034 T PT168240034 T PT 168240034T PT 16824003 T PT16824003 T PT 16824003T PT 3331508 T PT3331508 T PT 3331508T
- Authority
- PT
- Portugal
- Prior art keywords
- levobupivacaine hydrochloride
- solution injection
- levobupivacaine
- hydrochloride
- hyperbaric solution
- Prior art date
Links
- 229960001464 levobupivacaine hydrochloride Drugs 0.000 title 2
- SIEYLFHKZGLBNX-NTISSMGPSA-N levobupivacaine hydrochloride (anhydrous) Chemical compound [Cl-].CCCC[NH+]1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C SIEYLFHKZGLBNX-NTISSMGPSA-N 0.000 title 2
- 238000002347 injection Methods 0.000 title 1
- 239000007924 injection Substances 0.000 title 1
- 239000000243 solution Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2641MU2015 | 2015-07-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3331508T true PT3331508T (pt) | 2024-12-19 |
Family
ID=57757071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT168240034T PT3331508T (pt) | 2015-07-13 | 2016-04-01 | Solução de injeção hiperbárica de cloridrato de levobupivacaína compreendendo cloridrato de levobupivacaína |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20190070157A1 (pt) |
| EP (1) | EP3331508B1 (pt) |
| DK (1) | DK3331508T3 (pt) |
| FI (1) | FI3331508T3 (pt) |
| LT (1) | LT3331508T (pt) |
| PT (1) | PT3331508T (pt) |
| WO (1) | WO2017009862A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250082622A1 (en) * | 2023-09-12 | 2025-03-13 | Fresenius Kabi Austria Gmbh | Bupivacaine liquid formulations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8802564D0 (sv) * | 1988-07-08 | 1988-07-08 | Astra Ab | New synergistic preparations and a new method of alleviation of pain |
| KR100695588B1 (ko) * | 1997-11-19 | 2007-03-14 | 다윈 디스커버리 리미티드 | 마취용 제형물 |
| US6075059A (en) * | 1999-02-24 | 2000-06-13 | The Ohio State University | Compositions for dental anesthesia |
| JP2002069006A (ja) * | 2000-08-22 | 2002-03-08 | Maruishi Pharmaceutical Co Ltd | 局所麻酔剤組成物 |
| CN1628665A (zh) * | 2003-12-17 | 2005-06-22 | 北京博尔达生物技术开发有限公司 | 注射用左布比卡因冻干粉针剂及制备方法 |
-
2016
- 2016-04-01 WO PCT/IN2016/050101 patent/WO2017009862A1/en not_active Ceased
- 2016-04-01 PT PT168240034T patent/PT3331508T/pt unknown
- 2016-04-01 DK DK16824003.4T patent/DK3331508T3/da active
- 2016-04-01 FI FIEP16824003.4T patent/FI3331508T3/fi active
- 2016-04-01 EP EP16824003.4A patent/EP3331508B1/en active Active
- 2016-04-01 US US16/085,405 patent/US20190070157A1/en not_active Abandoned
- 2016-04-01 LT LTEPPCT/IN2016/050101T patent/LT3331508T/lt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3331508A4 (en) | 2019-06-19 |
| EP3331508B1 (en) | 2024-08-14 |
| US20190070157A1 (en) | 2019-03-07 |
| FI3331508T3 (fi) | 2024-11-14 |
| WO2017009862A1 (en) | 2017-01-19 |
| EP3331508C0 (en) | 2024-08-14 |
| EP3331508A1 (en) | 2018-06-13 |
| LT3331508T (lt) | 2024-12-27 |
| DK3331508T3 (da) | 2024-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201912792YA (en) | Therapeutic compounds and methods | |
| SMT202200358T1 (it) | Composizioni e metodi di rilascio degli agenti terapeutici | |
| SG10201802106TA (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
| SG10201802104QA (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
| ZA201706257B (en) | Treatment of wood | |
| ZA201802329B (en) | Hppd variants and methods of use | |
| ZA201903467B (en) | Transdermal delivery of large agents | |
| HUE056424T2 (hu) | Eljárások hatóanyagoknak a nyirokrendszerbe való bejuttatására | |
| ZA201902090B (en) | Combination treatments comprising administration of imidazopyrazinones | |
| IL285882A (en) | Medicinal uses for l–4–chlorokynurenine | |
| IL254273A0 (en) | Variants of protoxin-ii and methods of use | |
| IL282508A (en) | Variants of protoxin-II and methods of use | |
| IL255530A (en) | Efflux-pump inhibitors and therapeutic uses thereof | |
| PT3331516T (pt) | Solução de injeção hiperbárica de cloridrato de ropivacaína e processo para a sua preparação | |
| PT3331508T (pt) | Solução de injeção hiperbárica de cloridrato de levobupivacaína compreendendo cloridrato de levobupivacaína | |
| DK3453388T3 (da) | Farmaceutisk opløsning omfattende dopaminhydrochlorid | |
| GB201512139D0 (en) | Methods of treatment | |
| GB201608599D0 (en) | Treatment of opioid tollerence | |
| PT3453388T (pt) | Solução farmacêutica compreendendo cloridrato de dopamina | |
| GB201513922D0 (en) | Treatment of hyperpigmentation | |
| TWM489593U (en) | Improved structure of base for coat-hanging rack | |
| TH1501005346A (th) | องค์ประกอบทางเภสัชกรรมของเอส-คีตามีน ไฮโดรคลอไรด์ |